Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19.
Turecek PL, Peck RC, Rangarajan S, Reilly-Stitt C, Laffan MA, Kazmi R, James I, Dushianthan A, Schrenk G, Gritsch H, Ewenstein BM, Mellgard B, Erdlenbruch W, Jain N, Binder NB, Mumford AD. Turecek PL, et al. Among authors: ewenstein bm. Thromb Res. 2021 May;201:100-112. doi: 10.1016/j.thromres.2021.02.012. Epub 2021 Feb 18. Thromb Res. 2021. PMID: 33662796 Free PMC article.
Development of a plasma- and albumin-free recombinant von Willebrand factor.
Turecek PL, Mitterer A, Matthiessen HP, Gritsch H, Varadi K, Siekmann J, Schnecker K, Plaimauer B, Kaliwoda M, Purtscher M, Woehrer W, Mundt W, Muchitsch EM, Suiter T, Ewenstein B, Ehrlich HJ, Schwarz HP. Turecek PL, et al. Hamostaseologie. 2009 Oct;29 Suppl 1:S32-8. Hamostaseologie. 2009. PMID: 19763356
Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial.
Mannucci PM, Kempton C, Millar C, Romond E, Shapiro A, Birschmann I, Ragni MV, Gill JC, Yee TT, Klamroth R, Wong WY, Chapman M, Engl W, Turecek PL, Suiter TM, Ewenstein BM; rVWF Ad Hoc Study Group. Mannucci PM, et al. Among authors: ewenstein bm. Blood. 2013 Aug 1;122(5):648-57. doi: 10.1182/blood-2013-01-479527. Epub 2013 Jun 18. Blood. 2013. PMID: 23777763 Free PMC article. Clinical Trial.
The role of ultralarge multimers in recombinant human von Willebrand factor - a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand disease.
Turecek PL, Spannagl M, Kragh T, Allmaier G, Turecek M, Schrenk G, Gritsch H, Obermann-Slupetzky O, Ewenstein BM, Valentino LA. Turecek PL, et al. Among authors: ewenstein bm. Hamostaseologie. 2017;37(S 01):S15-S25. doi: 10.5482/HAMO-17-04-0018. Epub 2017 Dec 28. Hamostaseologie. 2017. PMID: 29582921 English.
Development of novel treatment options for patients with haemophilia.
Ehrlich HJ, Wong WY, Ewenstein BM, Dockal M, Turecek PL, Gringeri A, Chehadeh H, Löw-Baselli A, Scheiflinger F, Reininger AJ. Ehrlich HJ, et al. Among authors: ewenstein bm. Hamostaseologie. 2013;33 Suppl 1:S36-8. Hamostaseologie. 2013. PMID: 24169902 Review.
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
Pabinger I, Mamonov V, Windyga J, Engl W, Doralt J, Tangada S, Spotts G, Ewenstein B. Pabinger I, et al. Haemophilia. 2021 May;27(3):e331-e339. doi: 10.1111/hae.14219. Epub 2021 Mar 27. Haemophilia. 2021. PMID: 33772963 Free PMC article. Clinical Trial.
123 results